Cargando…

Inhibition of histone methyltransferase EZH2 depletes leukemia stem cell of mixed lineage leukemia fusion leukemia through upregulation of p16

Leukemia stem cells (LSC) are resistant to conventional chemotherapy and persistent LSC after chemotherapy are supposed to be a major cause of relapse. However, information on genetic or epigenetic regulation of stem cell properties is still limited and LSC-targeted drugs have scarcely been identifi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ueda, Koki, Yoshimi, Akihide, Kagoya, Yuki, Nishikawa, Satoshi, Marquez, Victor E, Nakagawa, Masahiro, Kurokawa, Mineo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317832/ https://www.ncbi.nlm.nih.gov/pubmed/24612037 http://dx.doi.org/10.1111/cas.12386

Ejemplares similares

Evi1 upregulates Fbp1 and supports progression of acute myeloid leukemia through pentose phosphate pathway activation
por: Mizuno, Hideaki, et al.
Publicado: (2021)

The histone methyltransferase EZH2 as a novel prosurvival factor in clinically aggressive chronic lymphocytic leukemia
por: Papakonstantinou, Nikos, et al.
Publicado: (2016)

Evi1 defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemia
por: Sato, T, et al.
Publicado: (2014)

Targeting histone methyltransferase and demethylase in acute myeloid leukemia therapy
por: Castelli, Germana, et al.
Publicado: (2017)

EZH2/EHMT2 Histone Methyltransferases Inhibit the Transcription of DLX5 and Promote the Transformation of Myelodysplastic Syndrome to Acute Myeloid Leukemia
por: Zheng, Zhuanzhen, et al.
Publicado: (2021)

EZH2 dependent epigenetic landscape in adult T cell leukemia and Tax immortalized cells
por: Fujikawa, Dai, et al.
Publicado: (2015)

Influence of Histone Deacetylase Inhibitors and DNA-Methyltransferase Inhibitors on the NK Cell-Mediated Lysis of Pediatric B-Lineage Leukemia
por: Pfeiffer, Matthias Manuel, et al.
Publicado: (2013)

Dual inhibition of EZH2 and G9A/GLP histone methyltransferases by HKMTI-1-005 promotes differentiation of acute myeloid leukemia cells
por: Sbirkov, Y., et al.
Publicado: (2023)

Leukemia cutis at onset of acute leukemia of ambiguous lineage
por: Lopez‐Andrade, Bernardo, et al.
Publicado: (2020)

ADAM8 Is an Antigen of Tyrosine Kinase Inhibitor-Resistant Chronic Myeloid Leukemia Cells Identified by Patient-Derived Induced Pluripotent Stem Cells
por: Miyauchi, Masashi, et al.
Publicado: (2018)

Dual roles of EZH2 in acute myeloid leukemia
por: Skoda, Radek C., et al.
Publicado: (2019)

Clinical Significance of EZH2 in Acute Myeloid Leukemia
por: Jiao, Weiyun, et al.
Publicado: (2022)

The histone methyltransferase Ezh2 restrains macrophage inflammatory responses
por: Kitchen, Gareth B., et al.
Publicado: (2021)

An Activating Mutation of the NSD2 Histone Methyltransferase Drives Oncogenic Reprogramming in Acute Lymphocytic Leukemia
por: Swaroop, Alok, et al.
Publicado: (2018)

Histone demethylase KDM2B upregulates histone methyltransferase EZH2 expression and contributes to the progression of ovarian cancer in vitro and in vivo
por: Kuang, Yan, et al.
Publicado: (2017)

Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer
por: Taniguchi, H, et al.
Publicado: (2012)

Thiopurine S-Methyltransferase and Methylenetetrahydrofolate Reductase Polymorphisms in Leukemia
por: KÜPELİ, Serhan
Publicado: (2015)

Retracted: Clinical Significance of EZH2 in Acute Myeloid Leukemia
por: Intelligence and Neuroscience, Computational
Publicado: (2023)

Evi1 forms a bridge between the epigenetic machinery and signaling pathways
por: Yoshimi, Akihide, et al.
Publicado: (2011)

Meningioma 1 is indispensable for mixed lineage leukemia-rearranged acute myeloid leukemia
por: Sharma, Amit, et al.
Publicado: (2020)

Inhibition of Euchromatic Histone Methyltransferase 1 and 2 Sensitizes Chronic Myeloid Leukemia Cells to Interferon Treatment
por: Loh, Sheng Wei, et al.
Publicado: (2014)

Targeting the histone H3 lysine 79 methyltransferase DOT1L in MLL-rearranged leukemias
por: Yi, Yan, et al.
Publicado: (2022)

Improved Therapeutic Effect against Leukemia by a Combination of the Histone Methyltransferase Inhibitor Chaetocin and the Histone Deacetylase Inhibitor Trichostatin A
por: Tran, Huong Thi Thanh, et al.
Publicado: (2013)

Unique Role of the WD-40 Repeat Protein 5 (WDR5) Subunit within the Mixed Lineage Leukemia 3 (MLL3) Histone Methyltransferase Complex
por: Shinsky, Stephen A., et al.
Publicado: (2015)

Thiopurine methyltransferase polymorphisms in children with acute lymphoblastic leukemia
por: Linga, Vijay Gandhi, et al.
Publicado: (2014)

Biphenotypic acute leukemia or acute leukemia of ambiguous lineage in childhood: clinical characteristics and outcome
por: Lee, Hyun Gyung, et al.
Publicado: (2019)

Acute lymphoblastic leukemia to acute myeloid leukemia: an unusual case report of lineage switching
por: Pandit, Sudarshan, et al.
Publicado: (2022)

The Histone Methyltransferase Inhibitor A-366 Uncovers a Role for G9a/GLP in the Epigenetics of Leukemia
por: Pappano, William N., et al.
Publicado: (2015)

New epigenetic pathway for stemness maintenance mediated by the histone methyltransferase Ezh1
por: Hidalgo, Isabel, et al.
Publicado: (2013)

Multiple regulatory aspects of histone methyltransferase EZH2 in Pb-induced neurotoxicity
por: Xue, Wei-Zhen, et al.
Publicado: (2017)

Targeting EZH2 histone methyltransferase activity alleviates experimental intestinal inflammation
por: Zhou, Jie, et al.
Publicado: (2019)

Histone Methyltransferase EZH2: A Potential Therapeutic Target for Kidney Diseases
por: Li, Tingting, et al.
Publicado: (2021)

Transcriptional and Microenvironmental Regulation of Lineage Ambiguity in Leukemia
por: Hu, Tianyuan, et al.
Publicado: (2017)

Acalabrutinib and steroid for autoimmune thrombocytopenia due to relapsed chronic lymphocytic leukemia with severe bone marrow infiltration
por: Oyama, Takashi, et al.
Publicado: (2023)

Acquisition of mixed lineage leukemia rearrangement in a chronic myeloid leukemia patient while on imatinib
por: Zámečníkova, Adriana
Publicado: (2011)

CD62L expression level determines the cell fate of myeloid progenitors
por: Ito, Yusuke, et al.
Publicado: (2021)

Using patient-derived iPSCs to develop humanized mouse models for chronic myelomonocytic leukemia and therapeutic drug identification, including liposomal clodronate
por: Taoka, Kazuki, et al.
Publicado: (2018)

Genetic polymorphisms of histone methyltransferase SETD2 predicts prognosis and chemotherapy response in Chinese acute myeloid leukemia patients
por: Wang, Suwei, et al.
Publicado: (2019)

Upregulation of SPINK2 in acute myeloid leukemia
por: Gezer, Sümbül, et al.
Publicado: (2023)

Acute myelogenous leukemia switch lineage upon relapse to acute lymphoblastic leukemia: a case report
por: Dorantes-Acosta, Elisa, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_rjp1nsd8demne2259p8nv81lko